News Evotec SE CBOE

Stocks

0IRF

DE0005664809

Biotechnology & Medical Research

Market Closed - CBOE 16:30:00 19/08/2026 BST			5-day change	1st Jan Change
3.724 ^EUR	0.00%		0.00%	-30.97%

08-13	Energiekontor hits March low, doubts over a strong second half	DP
08-13	Evotec's final first-half results once again spook investors	DP

All News

Mentions Relevance

08-13	Evotec's final first-half results once again spook investors	DP
08-13	Evotec SE Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-13	Evotec SE : Gets a Buy rating from RBC	ZD
08-13	Evotec : Half-year report 2026, PDF (H1 Report 2026 English)	PU
08-13	Evotec : Half-year report 2026, PDF (Interim Statement H1 2026 English)	PU
08-13	Evotec Se Announces Camilla Macapili Languille Step Down as Supervisory Board, Effective August 7, 2026	CI
08-13	Evotec Se Reaffirms Earnings Guidance for the Full-Year 2026	CI
08-06	Evotec, Odyssey Therapeutics Partner to Develop Autoimmune, Inflammatory Disease Treatments	MT
08-06	Evotec, Odyssey Therapeutics Team Up on Autoimmune, Inflammatory Disease Treatment Research	MT
08-06	Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases	EQ
08-06	Evotec : and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases	PU
08-03	Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168	CI
08-03	Niagen Bioscience, Evotec to Advance Preclinical Development of NB4168	MT
07-16	Berenberg Downgrades Evotec to Hold From Buy, Cuts Price Target to EUR3.60 From EUR9.40	MT
07-16	EVOTEC : Deutsche Bank reaffirms its Neutral rating	ZD
07-16	EVOTEC : Reduced to Neutral by Berenberg	ZD
07-16	Berenberg downgrades Evotec to 'Hold', target cut to €3.60	DP
07-15	Evotec Shares Fall After TD Cowen Downgrade	MT
07-15	TD Cowen Downgrades Evotec to Hold From Buy, Adjusts Price Target to $2 From $4	MT
07-14	Evotec SE, Q2 2026 Earnings Call, Jul 14, 2026
07-14	Evotec plunges after profit warning to lowest share price in ten years	DP
07-14	EVOTEC : Deutsche Bank reaffirms its Neutral rating	ZD
07-14	Evotec abandons profit hopes, shares slide	DP
07-14	EVOTEC : RBC gives a Buy rating	ZD
07-14	Evotec at risk of lowest share price in ten years after profit warning	DP